- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Colon Cancer Prevention: What Works?
A 50-year-old woman who has average risk for developing colorectal cancer undergoes a routine screening colonoscopy. Results are normal. She inquires about which medication she can take to reduce the risk of developing colon cancer. Based on the US Preventive Service Task Force, which of the following should be recommended?
A 50-year-old woman who has average risk for developing colorectal cancer undergoes a routine screening colonoscopy. Results are normal. She inquires about which medication she can take to reduce the risk of developing colon cancer. Based on the US Preventive Service Task Force, which of the following should be recommended?
A. Aspirin
B. Hormonal therapy
C. Statins
D. None of the above
Please leave your comment below.
Then click here for the answer and discussion.
Answer: D--None of the above
Although some studies have demonstrated a reduction in colon cancer with aspirin and other NSAIDs, theUS Preventive Service Task Forceconcluded that the harms of aspirin (eg, bleeding, hypertension, kidney damage) outweigh the benefits. Conflicting data exist regarding hormonal therapy and colon cancer risk; this medication cannot be recommended for this purpose. Finally, there is no hard evidence that statins reduce colon cancer risk.
Clinical Tips for Using Antibiotics and Corticosteroids in IBD
January 5th 2013The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.
